These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30500943)

  • 61. Pharmacological treatment of opioid use disorder in pregnancy.
    Rodriguez CE; Klie KA
    Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers.
    Woodcock EA; Lundahl LH; Greenwald MK
    Drug Alcohol Depend; 2015 Jan; 146():89-96. PubMed ID: 25479914
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study.
    Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M;
    BMJ Open; 2020 Jul; 10(7):e034389. PubMed ID: 32737087
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients.
    Vicknasingam B; Dazali MN; Singh D; Schottenfeld RS; Chawarski MC
    Drug Alcohol Depend; 2015 Jul; 152():164-9. PubMed ID: 25935736
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gestational changes in buprenorphine exposure: A physiologically-based pharmacokinetic analysis.
    Zhang H; Kalluri HV; Bastian JR; Chen H; Alshabi A; Caritis SN; Venkataramanan R
    Br J Clin Pharmacol; 2018 Sep; 84(9):2075-2087. PubMed ID: 29873094
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 68. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
    Terasaki D; Smith C; Calcaterra SL
    Pharmacotherapy; 2019 Oct; 39(10):1023-1029. PubMed ID: 31348544
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
    Gastberger S; Baumgartner MR; Soyka M; Quednow BB; Hulka LM; Herdener M; Seifritz E; Mutschler J
    Eur Addict Res; 2019; 25(4):207-212. PubMed ID: 31067528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Practical Approach for the Management of the Mixed Opioid Agonist-Antagonist Buprenorphine During Acute Pain and Surgery.
    Warner NS; Warner MA; Cunningham JL; Gazelka HM; Hooten WM; Kolla BP; Warner DO
    Mayo Clin Proc; 2020 Jun; 95(6):1253-1267. PubMed ID: 32061413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Case Series of Successful Postoperative Pain Management in Buprenorphine Maintenance Therapy Patients.
    Leighton BL; Crock LW
    Anesth Analg; 2017 Nov; 125(5):1779-1783. PubMed ID: 29049122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perioperative implications of buprenorphine maintenance treatment for opioid addiction.
    Gevirtz C; Frost EA; Bryson EO
    Int Anesthesiol Clin; 2011; 49(1):147-55. PubMed ID: 21239911
    [No Abstract]   [Full Text] [Related]  

  • 73. Simplified processing and rapid quantification of buprenorphine, norbuprenorphine, and their conjugated metabolites in human plasma using UPLC-MS/MS: Assessment of buprenorphine exposure during opioid use disorder treatment.
    Zhao W; Alshogran OY; Zhang H; Joshi A; Krans EE; Caritis S; Shaik IH; Venkataramanan R
    J Mass Spectrom; 2024 Apr; 59(4):e5015. PubMed ID: 38501738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study.
    Ling W; Nadipelli VR; Aldridge AP; Ronquest NA; Solem CT; Chilcoat H; Albright V; Johnson C; Learned SM; Mehra V; Heidbreder C
    J Addict Med; 2020; 14(5):e233-e240. PubMed ID: 32187112
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices.
    Greenwald M; Johanson CE; Bueller J; Chang Y; Moody DE; Kilbourn M; Koeppe R; Zubieta JK
    Biol Psychiatry; 2007 Jan; 61(1):101-10. PubMed ID: 16950210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials.
    Jones AK; Ngaimisi E; Gopalakrishnan M; Young MA; Laffont CM
    Clin Pharmacokinet; 2021 Apr; 60(4):527-540. PubMed ID: 33135125
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anesthesia considerations and post-operative pain management in pregnant women with chronic opioid use.
    Soens MA; He J; Bateman BT
    Semin Perinatol; 2019 Apr; 43(3):149-161. PubMed ID: 30791974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic opioid pain treatment converted to buprenorphine: A case series using a 3-step low-dose incremental dosing guideline.
    Acampora G; Zhang Y
    J Opioid Manag; 2024; 20(1):51-56. PubMed ID: 38533715
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
    Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
    J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.